Guetter, C.R., Badreg, A.M., Martinez, C., Moura, D.L., Espinoza, E.A., Krause, F.P., Vismara, L., Godoy, L.C., Serrano, M.L., Sampaio, P.H.M. de A., Batista, R.S. and Illigens, B.M.-W. 2018. Monoclonal antibody against CGRP (TEV-48125) for preventive treatment of episodic cluster headache: a phase II randomized clinical trial protocol. Principles and Practice of Clinical Research. 4, 1 (Jul. 2018), 14–20.